← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 1, 2013Last known activity
Mar 1, 2016
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 2 trials)
Phase 3 (1 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Recent trials (2)
- NCT02523911Lead sponsorN/AMar 1, 2016
- NCT02102555Overall official - principal investigatorPhase 3Oct 1, 2013
Details
- Last known activity
- Mar 1, 2016